Overview
Chunlai Zeng practices practicing medicine in Lishui, China.
Their clinical expertise encompasses Hypertension, Renovascular Hypertension, Atherosclerosis, and Cardiomyopathy.
They are actively involved in clinical research, co-authoring 49 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chunlai L. Zeng
Is Chunlai L. Zeng a top-rated expert for Hypertension?
MediFind is an objective health platform that identifies experts based on real-world data. Chunlai L. Zeng is classified as an Experienced expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chunlai L. Zeng participate in research or clinical trials?
Yes. Chunlai L. Zeng has published 49 articles and abstracts on conditions like Hypertension. You can view a list of Chunlai L. Zeng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AtherosclerosisZeng isExperienced. Learn about Atherosclerosis.
- CardiomyopathyZeng isExperienced. Learn about Cardiomyopathy.
- HypertensionZeng isExperienced. Learn about Hypertension.
- Renovascular HypertensionZeng isExperienced. Learn about Renovascular Hypertension.